Sung-Han Hsiao

604 total citations
22 papers, 471 citations indexed

About

Sung-Han Hsiao is a scholar working on Oncology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Sung-Han Hsiao has authored 22 papers receiving a total of 471 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 13 papers in Molecular Biology and 8 papers in Infectious Diseases. Recurrent topics in Sung-Han Hsiao's work include Drug Transport and Resistance Mechanisms (20 papers), HIV/AIDS drug development and treatment (8 papers) and Cancer therapeutics and mechanisms (7 papers). Sung-Han Hsiao is often cited by papers focused on Drug Transport and Resistance Mechanisms (20 papers), HIV/AIDS drug development and treatment (8 papers) and Cancer therapeutics and mechanisms (7 papers). Sung-Han Hsiao collaborates with scholars based in Taiwan and United States. Sung-Han Hsiao's co-authors include Chung‐Pu Wu, Yang-Hui Huang, Suresh V. Ambudkar, Tai‐Ho Hung, Yu‐Shan Wu, Sabrina Lusvarghi, Yanqing Li, Sheng‐Chieh Hsu, Megumi Murakami and Hong‐May Sim and has published in prestigious journals such as Cancer Research, International Journal of Molecular Sciences and Biochemical Pharmacology.

In The Last Decade

Sung-Han Hsiao

21 papers receiving 466 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sung-Han Hsiao Taiwan	14	308	299	99	45	42	22	471
Yang-Hui Huang Taiwan	12	308 1.0×	302 1.0×	93 0.9×	52 1.2×	45 1.1×	29	479
Guan-Nan Zhang United States	12	277 0.9×	249 0.8×	63 0.6×	23 0.5×	31 0.7×	17	425
Csilla Hegedüs Hungary	11	351 1.1×	217 0.7×	60 0.6×	22 0.5×	50 1.2×	13	444
Agnès Basseville United States	11	239 0.8×	321 1.1×	31 0.3×	23 0.5×	32 0.8×	18	521
Yue-Li Sun China	10	230 0.7×	248 0.8×	33 0.3×	31 0.7×	59 1.4×	23	535
Clara Lemos Netherlands	9	297 1.0×	451 1.5×	29 0.3×	66 1.5×	52 1.2×	10	698
Ioana Abraham China	7	220 0.7×	243 0.8×	46 0.5×	53 1.2×	22 0.5×	7	423
Maria A.J. van Eijndhoven Netherlands	7	356 1.2×	258 0.9×	52 0.5×	19 0.4×	73 1.7×	8	520
Mário Šereš Slovakia	13	261 0.8×	337 1.1×	31 0.3×	38 0.8×	18 0.4×	26	536
Bing Zhao China	10	168 0.5×	164 0.5×	49 0.5×	40 0.9×	64 1.5×	29	360

Countries citing papers authored by Sung-Han Hsiao

Since Specialization

Citations

This map shows the geographic impact of Sung-Han Hsiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sung-Han Hsiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sung-Han Hsiao more than expected).

Fields of papers citing papers by Sung-Han Hsiao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sung-Han Hsiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sung-Han Hsiao. The network helps show where Sung-Han Hsiao may publish in the future.

Co-authorship network of co-authors of Sung-Han Hsiao

This figure shows the co-authorship network connecting the top 25 collaborators of Sung-Han Hsiao. A scholar is included among the top collaborators of Sung-Han Hsiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sung-Han Hsiao. Sung-Han Hsiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liao, Wei‐Chao, Shiao-Wen Li, Sung-Han Hsiao, et al.. (2025). Respiratory microbiome and metabolome features associate disease severity and the need for doxycycline treatment in children with macrolide-resistant Mycoplasma pneumoniae-mediated pneumonia. Frontiers in Cellular and Infection Microbiology. 15. 1537182–1537182.

Wu, Chung‐Pu, Megumi Murakami, Sung-Han Hsiao, et al.. (2023). Furmonertinib, a Third-Generation EGFR Tyrosine Kinase Inhibitor, Overcomes Multidrug Resistance through Inhibiting ABCB1 and ABCG2 in Cancer Cells. International Journal of Molecular Sciences. 24(18). 13972–13972. 7 indexed citations

Wu, Chung‐Pu, Sung-Han Hsiao, & Yu‐Shan Wu. (2023). Perspectives on drug repurposing to overcome cancer multidrug resistance mediated by ABCB1 and ABCG2. Drug Resistance Updates. 71. 101011–101011. 23 indexed citations

Wu, Chung‐Pu, Sabrina Lusvarghi, Sung-Han Hsiao, et al.. (2021). Overexpression of Human ABCB1 and ABCG2 Reduces the Susceptibility of Cancer Cells to the Histone Deacetylase 6-Specific Inhibitor Citarinostat. International Journal of Molecular Sciences. 22(5). 2592–2592. 10 indexed citations

Wu, Chung‐Pu, Tai‐Ho Hung, Sabrina Lusvarghi, et al.. (2021). The third-generation EGFR inhibitor almonertinib (HS-10296) resensitizes ABCB1-overexpressing multidrug-resistant cancer cells to chemotherapeutic drugs. Biochemical Pharmacology. 188. 114516–114516. 29 indexed citations

Wu, Chung‐Pu, Megumi Murakami, Yu‐Shan Wu, et al.. (2021). Branebrutinib (BMS-986195), a Bruton’s Tyrosine Kinase Inhibitor, Resensitizes P-Glycoprotein-Overexpressing Multidrug-Resistant Cancer Cells to Chemotherapeutic Agents. Frontiers in Cell and Developmental Biology. 9. 699571–699571. 9 indexed citations

Wu, Chung‐Pu, Tai‐Ho Hung, Sung-Han Hsiao, et al.. (2020). Erdafitinib Resensitizes ABCB1-Overexpressing Multidrug-Resistant Cancer Cells to Cytotoxic Anticancer Drugs. Cancers. 12(6). 1366–1366. 33 indexed citations

Wu, Chung‐Pu, Sabrina Lusvarghi, Sung-Han Hsiao, et al.. (2020). Licochalcone A Selectively Resensitizes ABCG2-Overexpressing Multidrug-Resistant Cancer Cells to Chemotherapeutic Drugs. Journal of Natural Products. 83(5). 1461–1472. 28 indexed citations

Wu, Chung‐Pu, Sung-Han Hsiao, Yang-Hui Huang, et al.. (2020). Sitravatinib Sensitizes ABCB1- and ABCG2-Overexpressing Multidrug-Resistant Cancer Cells to Chemotherapeutic Drugs. Cancers. 12(1). 195–195. 41 indexed citations

10.

Hsiao, Sung-Han, Sabrina Lusvarghi, Yang-Hui Huang, et al.. (2019). The FLT3 inhibitor midostaurin selectively resensitizes ABCB1-overexpressing multidrug-resistant cancer cells to conventional chemotherapeutic agents. Cancer Letters. 445. 34–44. 32 indexed citations

11.

Wu, Chung‐Pu, Sabrina Lusvarghi, Sung-Han Hsiao, et al.. (2019). The Selective Class IIa Histone Deacetylase Inhibitor TMP195 Resensitizes ABCB1- and ABCG2-Overexpressing Multidrug-Resistant Cancer Cells to Cytotoxic Anticancer Drugs. International Journal of Molecular Sciences. 21(1). 238–238. 16 indexed citations

12.

Wu, Chung‐Pu, Sabrina Lusvarghi, Sung-Han Hsiao, et al.. (2019). Avapritinib: A Selective Inhibitor of KIT and PDGFRα that Reverses ABCB1 and ABCG2-Mediated Multidrug Resistance in Cancer Cell Lines. Molecular Pharmaceutics. 16(7). 3040–3052. 57 indexed citations

13.

Wu, Chung‐Pu, Megumi Murakami, Sung-Han Hsiao, et al.. (2018). SIS3, a specific inhibitor of Smad3 reverses ABCB1- and ABCG2-mediated multidrug resistance in cancer cell lines. Cancer Letters. 433. 259–272. 18 indexed citations

14.

Hsiao, Sung-Han, Megumi Murakami, Yanqing Li, et al.. (2018). The positive inotropic agent DPI-201106 selectively reverses ABCB1-mediated multidrug resistance in cancer cell lines. Cancer Letters. 434. 81–90. 8 indexed citations

15.

Wu, Chung‐Pu, Ya‐Ju Hsieh, Megumi Murakami, et al.. (2018). Human ATP-binding cassette transporters ABCB1 and ABCG2 confer resistance to histone deacetylase 6 inhibitor ricolinostat (ACY-1215) in cancer cell lines. Biochemical Pharmacology. 155. 316–325. 18 indexed citations

16.

Wu, Chung‐Pu, Megumi Murakami, Sung-Han Hsiao, et al.. (2017). Overexpression of ATP-Binding Cassette Subfamily G Member 2 Confers Resistance to Phosphatidylinositol 3-Kinase Inhibitor PF-4989216 in Cancer Cells. Molecular Pharmaceutics. 14(7). 2368–2377. 20 indexed citations

17.

Wu, Chung‐Pu, Sung-Han Hsiao, Megumi Murakami, et al.. (2017). Alpha-Mangostin Reverses Multidrug Resistance by Attenuating the Function of the Multidrug Resistance-Linked ABCG2 Transporter. Molecular Pharmaceutics. 14(8). 2805–2814. 25 indexed citations

18.

Wu, Chung‐Pu, Sung-Han Hsiao, Hong‐May Sim, et al.. (2013). Human ABCB1 (P-glycoprotein) and ABCG2 mediate resistance to BI 2536, a potent and selective inhibitor of Polo-like kinase 1. Biochemical Pharmacology. 86(7). 904–913. 29 indexed citations

19.

Wu, Chung‐Pu, Hong‐May Sim, Yang-Hui Huang, et al.. (2013). Abstract 3398: Overexpression of ATP-binding cassette transporter ABCG2 as a potential mechanism of acquired resistance to vemurafenib in BRAF(V600E) mutant cancer cells.. Cancer Research. 73(8_Supplement). 3398–3398. 1 indexed citations

20.

Wu, Chung‐Pu, Hong‐May Sim, Yang-Hui Huang, et al.. (2012). Overexpression of ATP-binding cassette transporter ABCG2 as a potential mechanism of acquired resistance to vemurafenib in BRAF(V600E) mutant cancer cells. Biochemical Pharmacology. 85(3). 325–334. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact